Abiopharma

COTY INC. (COTY) Reports the reporting period Financial Results COTY INC. (COTY) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: (1
• Net Income: (15
• EPS: (0.36)
• Cash and equivalents: $422
  • planned for FY27 under several core brands, coupled with the all-new Swarovski fragrance targeted to launch in CY27 Consumer Beauty Plans•CoverGirl and Sally Hansen have narrowed the retail sales gap to their respective categories in the U.S., while outperforming on a volume basis, fueled by stepped up support of iconic franchises coupled with outperformance in its Spring innovations•Continuing to expand and amplify adidas fragrances globally, led by the adidas Vibes scenting collection, with adidas fragrance sales growing in Q3 and fiscal year-to-dateOutlookConsumer demand for beauty remains resilient, with continued growth in fragrances and cosmetics. While the conflict in the Middle East continues to weigh on sales trends in the region, consumer demand in developed markets has remained broadly consistent with recent periods. Against this backdrop, Coty is steadily implementing its Coty.Curated strategic framework, focusing on core brands and markets, reducing portfolio complexity, and identifying savings opportunities across the P&L to support increased investment in consumer engagement and protect profitability. Coty expects fourth quarter FY26 LFL revenue to decline by a mid‑single‑digit percentage, reflecting a moderate sequential improvement from third quarter sales trends. This outlook embeds a benefit from an easier prior‑year comparison base, largely offset by headwinds in the Middle East business, which is expected to impact fourth quarter sales by an estimated 2% to 3%. On a reported basis, Coty expects foreign exchange to have a neutral impact in the quarter.Adjusted gross margins are expected to decline by approximately 100 to 200 basis points year-on-year, reflecting operating deleverage from lower shipments, tariff impact, and elevated, though sequentially lower, excess and obsolescence, partially offset by productivity initiatives and procurement actions.Coty anticipates FY26 adjusted EBITDA of approximately $838 million to $848 million, with an adjusted EPS, excluding the equity swap, of $0.33 to $0.35. Coty's stronger-than-guided Q3 profit delivery, supported by tight cost control and a decision to reallocate some investment to Q4, is allowing the company to protect investments during key Q4 commercial periods, particularly Mother's Day and Father's Day. Based on this cadence, Coty estimates Q4 adjusted EBITDA of $85 million to $95 million and adjusted EPS, excluding the equity swap, of breakeven to a loss of $0.02 per share.Finally, Coty expects free cash flow in the fourth quarter to be neutral to moderately positive, reflecting the seasonality of the business and disciplined working capital management.4 Third Quarter Fiscal 2026